US Stock MarketDetailed Quotes

TFX Teleflex

Watchlist
  • 207.380
  • -0.920-0.44%
Close Apr 18 16:00 ET
  • 207.380
  • 0.0000.00%
Post 16:20 ET
9.77BMarket Cap27.54P/E (TTM)

About Teleflex Company

Teleflex, Inc. provides medical technology products which enable healthcare providers to improve patient outcomes and enhance patient and provider safety. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.

Company Profile

SymbolTFX
Company NameTeleflex
Listing DateApr 28, 1994
Founded1943
CEOMr. Liam J. Kelly
MarketNYSE
Employees14500
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address550 East Swedesford Road,Suite 400
CityWayne
ProvincePennsylvania
CountryUnited States of America
Zip Code19087
Phone1-610-225-6800

Company Executives

  • Name
  • Position
  • Salary
  • Liam J. Kelly
  • Chairman of the Board, President and Chief Executive Officer
  • 9.04M
  • Thomas E. Powell
  • Executive Vice President and Chief Financial Officer
  • 2.60M
  • John Deren
  • Corporate Vice President and Chief Accounting Officer
  • --
  • Jay White
  • Corporate Vice President and President, Global Commercial
  • 2.37M
  • James Winters
  • Corporate Vice President, Manufacturing and Supply Chain
  • 1.62M
  • Daniel V. Logue
  • Corporate Vice President, General Counsel and Secretary
  • 1.81M
  • Cameron P. Hicks
  • Corporate Vice President, Human Resources and Communications
  • 1.09M
  • Neena M. Patil
  • Independent Director
  • 301.20K
  • Stuart A. Randle
  • Independent Director
  • 324.53K
  • Andrew A. Krakauer
  • Independent Director
  • 308.28K
  • Gretchen R. Haggerty
  • Independent Director
  • 308.20K
  • Stephen K. Klasko
  • Lead Independent Director
  • 350.30K
  • John C. Heinmiller
  • Independent Director
  • 308.20K
  • Candace H. Duncan
  • Independent Director
  • 331.70K
  • Dr. Jaewon Ryu, J.D.,M.D.
  • Independent Director
  • 364.30K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg